A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Reply to Leibovici et al
2010
Clinical Infectious Diseases
Preserved Fulltext
cible way of searching for trials introduced bias into the FDA meta-analysis. In trials that were published, with use of the FDA data, the relative risk for mortality associated with cefepime was 1.23 (95% confidence interval, 1.07-1.42; with no heterogeneity, ; ie, cefepime was 2
doi:10.1086/657248
fatcat:fbzqbwdf7bfvpdldnwkoozniyu